Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy.
about
Targeting Zinc Finger Domains with Small Molecules: Solution Structure and Binding Studies of the RanBP2-Type Zinc Finger of RBM5Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.New anti-HIV agents and targets.Initial therapy for human immunodeficiency virus: broadening the options.A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions.Novel compounds for the treatment of HIV type-1 infection.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.
P2860
Q27676146-AFFB304F-F215-48DD-9CD9-4794D676A20CQ34616490-21416E84-4AE1-43EF-A946-17A7B44B04E4Q34768558-45130210-1421-4743-9CF0-B96DA284226DQ34944447-458120BB-0278-4770-ABDA-470B3A81639EQ35759609-01559679-C984-4795-9792-1C4A9CC6D43EQ36523852-A83CE283-CFA6-477E-8130-D4807855642CQ37502492-30EC0F67-CC16-4B74-9FD0-229FEC71EED7Q40055204-4E09C503-267C-47C8-A0DA-89F3C454137A
P2860
Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Phase I/II dose escalation and ...... urrent antiretroviral therapy.
@ast
Phase I/II dose escalation and ...... urrent antiretroviral therapy.
@en
type
label
Phase I/II dose escalation and ...... urrent antiretroviral therapy.
@ast
Phase I/II dose escalation and ...... urrent antiretroviral therapy.
@en
prefLabel
Phase I/II dose escalation and ...... urrent antiretroviral therapy.
@ast
Phase I/II dose escalation and ...... urrent antiretroviral therapy.
@en
P2093
P1433
P1476
Phase I/II dose escalation and ...... current antiretroviral therapy
@en
P2093
E de Clercq
F D Goebel
J C Schmit
J P Tassignon
J R Bogner
M Vandevelde
M Witvrouw
P356
10.1097/00002030-200101050-00007
P407
P577
2001-01-01T00:00:00Z